Feasibility of Using Tablet-Based Cognitive Screening Tools in India: A Short Review

Literature Review

The last decade or so has witnessed the introduction of mobile devices and tablet computers, and the continued use of these devices by people across the world. Following the increased demand, and their efficiency for regular use, countries such as the USA, UK, Denmark, Japan, have begun standardizing and validating tablet based cognitive screening batteries. Test batteries such as, the Oxford Cognitive Screening- Plus (OCS-Plus), a screening test for dementia (Humphreys, Duta, Montana, Demeyere, McCrory, Rohr, Kahn, Tollman, & Berkman, 2017), the Memory Orientation Screening Test (MOST) for identifying neurocognitive disorders in the elderly (Clionsky & Clionsky, 2014), the self-administered iPad based test on processing speed (Rao, Losinski, Mourany, Schindler, Mamone, Reece, Kemeny, Narayanan, Miller, Bethoux, Bermel, Rudick, & Alberts, 2017) and performance test (MSPT- Rudick, Miller, Bethoux, Rao, Lee, Stough, Reece, Schindler, Mamone, & Alberts, 2014) for multiple sclerosis patients, the Cognitive Assessment at Bedside – iPad version (CABPad) - a cognitive screening device for stroke patients (Willer, Pedersen, Forchhammer, & Christensen, 2016), the Cleveland Clinic Concussion app (C3 app) a mobile app for assessing the neuropsychological condition of sports player on the field following a concussion (Alberts & Linder, 2015), and the iPad version of ACE-III (ACEmobile) for early detection of dementia (Hsieh, Schubert, Hoon, Mioshi, & Hodges, 2013) are now available to clinical and research professionals.